Medicare Enrolled
Dr. James O'Bryon, O.D., M.D.
Optometrist · Du Bois, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. O'Bryon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Bryon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. O'Bryon
Dr. James O'Bryon is an optometrist in Du Bois, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. O'Bryon performed 6,413 Medicare services across 3,596 unique beneficiaries.
Between the years covered by Open Payments, Dr. O'Bryon received a total of $12,982 from 61 pharmaceutical and/or device companies across 979 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. O'Bryon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in PA
$12,982 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,413
Medicare services
Top 0% in PA for optometrist
3,596
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~321 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
872 | $56 | $125 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
838 | $8 | $10 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
419 | $77 | $120 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
353 | $126 | $260 |
| Annual depression screening | 338 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
310 | $84 | $165 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
221 | $9 | $20 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
215 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
205 | $72 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
203 | $9 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
198 | $10 | $30 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
195 | $13 | $25 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
67 | $29 | $65 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
52 | $2 | $12 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
49 | $210 | $300 |
| PSA test (prostate cancer screening) | 43 | $18 | $50 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
37 | $6 | $20 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
37 | $5 | $12 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
37 | $16 | $30 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
37 | $37 | $80 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
37 | $157 | $260 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
26 | $162 | $260 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
24 | $16 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
22 | $9 | $50 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
20 | $281 | $300 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $29 | $30 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
14 | $36 | $73 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $34 | $70 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
11 | $22 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,982
Total received (2018-2024)
Avg $1,855/year across 7 years
Top 2% in PA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
979
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,982 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,495
2023
$1,227
2022
$1,959
2021
$2,625
2020
$1,904
2019
$1,861
2018
$1,911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$288
AstraZeneca Pharmaceuticals LP
$257
Phathom Pharmaceuticals, Inc.
$152
Astellas Pharma US Inc
$151
Amgen Inc.
$139
PFIZER INC.
$78
Lilly USA, LLC
$71
Exact Sciences Corporation
$62
Otsuka America Pharmaceutical, Inc.
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Abbott Laboratories
$39
Xeris Pharmaceuticals, Inc.
$31
VIVUS LLC
$24
ABBVIE INC.
$21
Kyowa Kirin, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$17
GlaxoSmithKline, LLC.
$17
SANOFI PASTEUR INC.
$16
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,101
AstraZeneca Pharmaceuticals LP
$1,121
Janssen Pharmaceuticals, Inc
$1,005
PFIZER INC.
$789
Amgen Inc.
$782
Kowa Pharmaceuticals America, Inc.
$556
Lilly USA, LLC
$534
Astellas Pharma US Inc
$424
Amarin Pharma Inc.
$392
ABBVIE INC.
$349
Merck Sharp & Dohme LLC
$329
GlaxoSmithKline, LLC.
$293
Takeda Pharmaceuticals U.S.A., Inc.
$290
Daiichi Sankyo Inc.
$277
Allergan, Inc.
$271
Merck Sharp & Dohme Corporation
$245
AbbVie Inc.
$243
SANOFI-AVENTIS U.S. LLC
$213
Eisai Inc.
$205
Allergan Inc.
$199
Phathom Pharmaceuticals, Inc.
$184
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$156
Alcon Vision LLC
$150
Abbott Laboratories
$130
Otsuka America Pharmaceutical, Inc.
$115
Johnson & Johnson Vision Care, Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Exact Sciences Corporation
$101
SANOFI PASTEUR INC.
$98
Teva Pharmaceuticals USA, Inc.
$93
GENZYME CORPORATION
$92
Radius Health, Inc.
$78
BioFire Diagnostics, LLC
$74
Biohaven Pharmaceuticals, Inc.
$69
Biohaven Pharmaceutical Holding Company Ltd.
$66
Biogen, Inc.
$61
Horizon Therapeutics plc
$60
Alfasigma USA, Inc.
$59
Esperion Therapeutics, Inc.
$47
Shire North American Group Inc
$44
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Novartis Pharmaceuticals Corporation
$41
Masimo Corporation
$31
Xeris Pharmaceuticals, Inc.
$31
AbbVie, Inc.
$30
Nestle HealthCare Nutrition Inc.
$29
VIVUS LLC
$24
CooperVision Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Avanir Pharmaceuticals, Inc.
$20
Dexcom, Inc.
$20
Kyowa Kirin, Inc.
$20
Carl Zeiss Meditec AG
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
EISAI INC.
$16
Currax Pharmaceuticals LLC
$15
Regeneron Healthcare Solutions, Inc.
$14
Aerie Pharmaceuticals, Inc.
$14
Medtronic, Inc.
$13
Sanofi Pasteur Inc.
$13
Alcon Laboratories Inc
$12
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · AJOVY · Acuvue · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEXSERO · BEYFORTUS · BREO · BREZTRI · BYDUREON · BYSTOLIC · BioFire FilmArray · CHANTIX · COMIRNATY · Cequa · Cologuard Collection Kit · Crysvita · DAILIES · DALVANCE · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENDURANT IIS · ENTRESTO · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GLASSIA · GVOKE HYPOPEN · Humira · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · LYRICA · Livalo · MENQUADFI · MOUNJARO · MYRBETRIQ · MyDay Contact Lens · Myrbetriq · NEXLETOL · NURTEC ODT · None Specified · Nuedexta · OCTRODE · OFEV · ONZETRA XSAIL · Otezla · Ozempic · PANCREAZE · PENTACEL · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Precision 1 · Prolia · QULIPTA · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rhopressa · Rybelsus · SEGLENTIS · SET and rainbow SET · SHINGRIX · SOLIQUA 100/33 · SYMBICORT · SYNTHROID · Saxenda · Synthroid · Systane · TEPEZZA · TOTAL30 · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIIDRA · ZENPEP · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for optometrist in PA.
Geographic Context
Optometrists within 10 mi
41
Per 100K population
52.0
County median income
$60,181
Nearest hospital
PENN HIGHLANDS DUBOIS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. O'Bryon is a clinical cardiology specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 2% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. O'Bryon experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. O'Bryon performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Bryon receive payments from pharmaceutical companies?
Yes. Dr. O'Bryon received a total of $12,982 from 61 companies across 979 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Bryon's costs compare to other optometrists in Du Bois?
Dr. O'Bryon's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Bryon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Optometrists in Du Bois
Browse optometrists in Du Bois ranked by procedure volume and transparency data.
Highest volume
Top Optometrists in PA
Optometrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Optometrists in PA
Which PA optometrists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology